Literature DB >> 9573311

Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses.

T Hatziioannou1, S Valsesia-Wittmann, S J Russell, F L Cosset.   

Abstract

We describe retrovirus particles carrying the fowl plague virus (FPV) hemagglutinin (HA). When expressed in cells providing Moloney murine leukemia virus (MoMLV) Gag and Pol proteins and a lacZ retroviral vector, FPV HA was found to be efficiently expressed, correctly processed, and stably incorporated into retroviral particles. HA-bearing retroviruses were infectious with a wide host range and were only 10-fold less infectious than retroviruses carrying wild-type MLV retroviral envelopes. We also coexpressed HA proteins in retroviral particles with chimeric MoMLV-derived envelope glycoproteins that efficiently retarget virus attachment but are only weakly fusogenic. Our results suggest that HA can in some cases enhance the fusion ability of these retroviral particles, depending on the cell surface molecule that is used as a receptor.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9573311      PMCID： PMC116395          DOI： 10.1128/JVI.72.6.5313-5317.1998

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  15 in total

1.  A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.

Authors:  J Dong; M G Roth; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

Review 2.  Membrane fusion.

Authors:  J M White
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

Review 3.  Targeting retrovirus entry.

Authors:  F L Cosset; S J Russell
Journal:  Gene Ther       Date:  1996-11       Impact factor: 5.250

4.  Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.

Authors:  W S Chen; C S Lazar; K A Lund; J B Welsh; C P Chang; G M Walton; C J Der; H S Wiley; G N Gill; M G Rosenfeld
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

Review 5.  The structure and function of the hemagglutinin membrane glycoprotein of influenza virus.

Authors:  D C Wiley; J J Skehel
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

6.  Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein.

Authors:  M Ohuchi; A Cramer; M Vey; R Ohuchi; W Garten; H D Klenk
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

8.  A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses.

Authors:  L H Evans; R P Morrison; F G Malik; J Portis; W J Britt
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  Structure of influenza haemagglutinin at the pH of membrane fusion.

Authors:  P A Bullough; F M Hughson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

Review 10.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937
View more
  12 in total

1.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Targeting lentiviral vectors to specific cell types in vivo.

Authors:  Lili Yang; Leslie Bailey; David Baltimore; Pin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 3.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

4.  Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.

Authors:  Patrick L Sinn; Erin R Burnight; Melissa A Hickey; Gary W Blissard; Paul B McCray
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Properties of wild-type, C-terminally truncated, and chimeric maedi-visna virus glycoprotein and putative pseudotyping of retroviral vector particles.

Authors:  U Zeilfelder; V Bosch
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  High efficiency gene transfer to airways of mice using influenza hemagglutinin pseudotyped lentiviral vectors.

Authors:  Manij Patel; Angela M Giddings; John Sechelski; John C Olsen
Journal:  J Gene Med       Date:  2013-01       Impact factor: 4.565

7.  Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.

Authors:  Eve-Isabelle Pécheur; Dimitri Lavillette; Fanny Alcaras; Jennifer Molle; Yury S Boriskin; Michael Roberts; François-Loïc Cosset; Stephen J Polyak
Journal:  Biochemistry       Date:  2007-04-25       Impact factor: 3.162

8.  Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses.

Authors:  Judit Szécsi; Bertrand Boson; Per Johnsson; Pia Dupeyrot-Lacas; Mikhail Matrosovich; Hans-Dieter Klenk; David Klatzmann; Viktor Volchkov; François-Loïc Cosset
Journal:  Virol J       Date:  2006-09-03       Impact factor: 4.099

Review 9.  Pseudotype-based neutralization assays for influenza: a systematic analysis.

Authors:  George William Carnell; Francesca Ferrara; Keith Grehan; Craig Peter Thompson; Nigel James Temperton
Journal:  Front Immunol       Date:  2015-04-29       Impact factor: 7.561

10.  A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.

Authors:  Nigel J Temperton; Katja Hoschler; Diane Major; Carolyn Nicolson; Ruth Manvell; Vo Minh Hien; Do Quang Ha; Menno de Jong; Maria Zambon; Yasuhiro Takeuchi; Robin A Weiss
Journal:  Influenza Other Respir Viruses       Date:  2007-05       Impact factor: 4.380
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.